NEE-75355-59527 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-09-20
Dose 1 — Pfizer-BioNTech
Co-administered: Flu:Hepatitis B:Hib:Polio:Rotavirus:Tetanus
2022-09-22
Registered in v-safe
2022-09-24
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-09-25
Survey response — days 1–6 daily, dose 1, under 3
MedDRA: Gastrooesophageal reflux disease — Feeling: Good

Free text: Spit upy

MedDRA releases: 2024-11 · check-in free text available
2023-03-21
Health check-in — 6 months, dose 1, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-09-20	Pfizer-BioNTech	Flu:Hepatitis B:Hib:Polio:Rotavirus:Tetanus

Free text

Release 12 (Under 3) — days 1–6 daily, dose 1, under 3

2022-09-25

Systemic reaction (other): Spit upy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Gastrooesophageal reflux disease	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release